Cumberland Pharmaceuticals Inc (CPIX)
1.20
+0.06
(+5.26%)
USD |
NASDAQ |
Nov 05, 16:00
1.20
0.00 (0.00%)
After-Hours: 16:00
Cumberland Pharmaceuticals Total Liabilities (Quarterly): 52.49M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 52.49M |
| March 31, 2024 | 54.32M |
| December 31, 2023 | 52.52M |
| September 30, 2023 | 52.10M |
| June 30, 2023 | 52.54M |
| March 31, 2023 | 53.42M |
| December 31, 2022 | 56.95M |
| September 30, 2022 | 52.29M |
| June 30, 2022 | 53.31M |
| March 31, 2022 | 55.90M |
| December 31, 2021 | 41.86M |
| September 30, 2021 | 40.92M |
| June 30, 2021 | 41.04M |
| March 31, 2021 | 46.47M |
| December 31, 2020 | 49.59M |
| September 30, 2020 | 48.17M |
| June 30, 2020 | 49.11M |
| March 31, 2020 | 47.58M |
| December 31, 2019 | 53.46M |
| September 30, 2019 | 52.06M |
| June 30, 2019 | 53.86M |
| March 31, 2019 | 59.43M |
| December 31, 2018 | 57.12M |
| September 30, 2018 | 29.49M |
| June 30, 2018 | 30.77M |
| Date | Value |
|---|---|
| March 31, 2018 | 30.22M |
| December 31, 2017 | 29.31M |
| September 30, 2017 | 25.43M |
| June 30, 2017 | 21.31M |
| March 31, 2017 | 19.65M |
| December 31, 2016 | 20.28M |
| September 30, 2016 | 16.65M |
| June 30, 2016 | 13.51M |
| March 31, 2016 | 13.89M |
| December 31, 2015 | 15.10M |
| September 30, 2015 | 14.52M |
| June 30, 2015 | 14.21M |
| March 31, 2015 | 12.85M |
| December 31, 2014 | 14.65M |
| September 30, 2014 | 13.02M |
| June 30, 2014 | 12.74M |
| March 31, 2014 | 12.15M |
| December 31, 2013 | 8.322M |
| September 30, 2013 | 10.98M |
| June 30, 2013 | 12.59M |
| March 31, 2013 | 13.25M |
| December 31, 2012 | 13.03M |
| September 30, 2012 | 13.60M |
| June 30, 2012 | 12.17M |
| March 31, 2012 | 12.72M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
40.92M
Minimum
Sep 2021
56.95M
Maximum
Dec 2022
50.21M
Average
52.29M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 78.52M |
| Shareholders Equity (Quarterly) | 26.35M |
| Debt to Equity Ratio | 0.6107 |
| Current Ratio | 1.437 |
| Net Debt Paydown Yield | -0.02% |